Jane Street Group, LLC Cytokinetics Inc Transaction History

Jane Street Group, LLC

$481 Billion
Q2 2025

A detailed history of Jane Street Group, LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Jane Street Group, LLC holds 516,500 shares of CYTK stock, worth $17.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

516,500

Previous 755,706 31.65%

Holding current value

$17.7 Million

Previous $30.4 Million 43.81%

% of portfolio

0.0%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$29.84 - $42.92 $19.4 Million - $27.9 Million	-649,598 Reduced 85.96%	106,108 $3.51 Million
Q1 2025 May 14, 2025	BUY	$40.19 - $51.12 $26 Million - $33.1 Million	647,584 Added 598.94%	755,706 $30.4 Million
Q4 2024 Feb 14, 2025	BUY	$46.36 - $58.62 $1.06 Million - $1.34 Million	22,799 Added 26.72%	108,122 $5.09 Million
Q3 2024 Nov 14, 2024	SELL	$51.22 - $60.16 $9.2 Million - $10.8 Million	-179,679 Reduced 67.8%	85,323 $4.51 Million
Q2 2024 Aug 14, 2024	SELL	$47.86 - $75.05 $2.04 Million - $3.19 Million	-42,565 Reduced 13.84%	265,002 $14.4 Million
Q1 2024 May 15, 2024	BUY	$63.75 - $108.06 $14 Million - $23.7 Million	218,986 Added 247.22%	307,567 $21.6 Million
Q4 2023 Feb 14, 2024	SELL	$26.88 - $83.49 $980,017 - $3.04 Million	-36,459 Reduced 29.16%	88,581 $7.4 Million
Q3 2023 Nov 14, 2023	SELL	$29.46 - $36.61 $658,313 - $818,087	-22,346 Reduced 15.16%	125,040 $3.68 Million
Q2 2023 Aug 14, 2023	BUY	$32.62 - $40.75 $2.17 Million - $2.71 Million	66,574 Added 82.38%	147,386 $4.81 Million
Q1 2023 May 15, 2023	SELL	$33.36 - $45.71 $3.18 Million - $4.36 Million	-95,292 Reduced 54.11%	80,812 $2.84 Million
Q4 2022 Feb 14, 2023	SELL	$35.77 - $51.11 $6.53 Million - $9.34 Million	-182,648 Reduced 50.91%	176,104 $8.07 Million
Q3 2022 Nov 14, 2022	BUY	$38.54 - $54.52 $9.04 Million - $12.8 Million	234,502 Added 188.73%	358,752 $17.4 Million
Q2 2022 Aug 16, 2022	BUY	$33.93 - $48.92 $2.26 Million - $3.25 Million	66,491 Added 115.12%	124,250 $4.88 Million
Q1 2022 May 17, 2022	SELL	$29.74 - $46.0 $134,097 - $207,414	-4,509 Reduced 7.24%	57,759 $2.13 Million
Q4 2021 Feb 15, 2022	BUY	$34.35 - $46.38 $1.76 Million - $2.38 Million	51,279 Added 466.64%	62,268 $2.84 Million
Q3 2021 Nov 16, 2021	SELL	$18.54 - $35.74 $61,478 - $118,513	-3,316 Reduced 23.18%	10,989 $393,000
Q2 2021 Aug 16, 2021	SELL	$19.79 - $26.99 $1.41 Million - $1.92 Million	-71,035 Reduced 83.24%	14,305 $283,000
Q4 2020 Feb 17, 2021	BUY	$15.26 - $28.61 $449,895 - $843,480	29,482 Added 52.78%	85,340 $1.77 Million
Q3 2020 Nov 17, 2020	BUY	$20.58 - $28.96 $942,090 - $1.33 Million	45,777 Added 454.09%	55,858 $1.21 Million
Q2 2020 Aug 17, 2020	SELL	$11.15 - $24.64 $527,629 - $1.17 Million	-47,321 Reduced 82.44%	10,081 $238,000
Q4 2019 Feb 14, 2020	BUY	$7.95 - $11.84 $456,345 - $679,639	57,402 New	57,402 $609,000

Others Institutions Holding CYTK

# of Institutions

368

Shares Held

129M

Call Options Held

3.62M

Put Options Held

1.12M

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $3.23B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Cytokinetics Inc Transaction History